CD38, Human (Daratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD38, Human (Daratumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD38, Human (Daratumumab biosimilar)
CloneDaratumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsWB, IP, IF, FuncS, FCM, Neut, ELISA
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD38 Recombinant Antibody (Daratumumab). Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.
Immunogenn/a
Other NamesAnti-CD38 Recombinant Antibody, Research Grade Daratumumab, Anti-Human CD38 Recombinant Antibody(Daratumumab), HuMax-CD38, Antibody Drug Analogues, Monoclonal Antibody, YR1199, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 945721-28-8
Catalog #YR1199
Priceplease inquire
Order / More InfoCD38, Human (Daratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.